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markers of oxidative stress are elevated in the orbitofrontal cortex 
in post-mortem samples of ASC patients (Sajdel-Sulkowska et al., 
2011). This region is thus a likely candidate for an underlying cel-
lular mechanism.
Nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-κB) is a protein that controls transcription of DNA and is 
found in almost all cell types (Perkins, 2004). It mediates cellular 
response to external stressors and is central to the regulation of 
immune responses by inducing the expression of inflammatory 
cytokines and chemokines and, in turn, being induced by them 
(Pahl, 1999; Perkins, 2004). This establishes a positive feedback 
mechanism (Larsson et al., 2005) which, when NF-κB becomes 
aberrantly active, has the potential to produce chronic or excessive 
inflammation associated with several inflammatory diseases (Pahl, 
1999). Furthermore, post-mortem studies suggest that NF-κB plays 
a key role in Alzheimer’s disease (Akiyama et al., 1994) and its pos-
sible treatment (Paris et al., 2007), Parkinson’s disease (Block and 
Hong, 2005) and multiple sclerosis (Glass et al., 2010).
Microglia mediate the immune responses of the central nervous 
system acting to remove extracellular debris with a similar func-
tion to macrophages. Microglial cells have been associated with 
IntroductIon
Autism spectrum condition (ASC) is a life-long neurodevelop-
mental condition characterized by a triad of impairments in social 
skills, verbal communication, and behavior (Rapin, 1997; Lord 
et al., 2000). Cognitively, ASC is described as a disorder involving 
fundamental deficits in central coherence (Frith, 1989), executive 
function (Ornitz et al., 1993), theory of mind (Baron-Cohen et al., 
1985), and empathizing (Baron-Cohen, 2002). Continuing inves-
tigations for a neurobiological basis for ASC support the view that 
genetic, environmental, neurological, and immunological factors 
contribute to its etiology (Neuhaus et al., 2010). In particular, there 
is evidence to suggest an association between ASC and neuroin-
flammation in anterior regions of the neocortex (Pardo et al., 2005; 
Vargas et al., 2005; Zimmerman et al., 2005), and areas relating to 
cognitive function appear to be affected by inflammation resulting 
from activation of microglia and astrocytes (Anderson et al., 2008). 
In vivo measurements of structural brain changes with magnetic 
resonance imaging have detected gray matter loss in the orbitofron-
tal cortex (Hardan et al., 2006; Girgis et al., 2007) and impairment 
of cognitive functions mediated by the orbitofrontal–amygdala 
circuit (Loveland et al., 2008) in patients with ASC. Furthermore, 
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NF-κB, and thus its potential for nuclear translocation. The 
expression of active NF-κB translocated to the cell nuclei was 
then measured directly, where it binds to DNA and transcribes 
proteins that result in the production of cytokines as part of an 
inflammatory response.
Confirmation of the immunodetection and immunofluores-
cence results in neurons and mature microglia was sought from 
an independent source of micro-array tissue slides donated from 
ASC patient and control groups.
Finally, pH was measured in homogenized tissue and com-
pared to the corresponding intracellular NF-κB p65 expression 
from Western immunodetection. Acridine orange staining allowed 
measurements of pH localized to lysosomes.
MaterIals and Methods
tIssue saMples
The UK cohort consisted of seven samples of fixed orbitofrontal 
cortex sections from four control and three ASC donors obtained 
from the Medical Research Council’s London Brain Bank (Institute 
of Psychiatry, King’s College London). Samples were age, sex, and 
post-mortem interval (PMI) matched (Table 1). Protein extrac-
tion from formalin fixed tissue was performed according to Shi 
et al. (2006), where tissue sections were placed in 50 μl of 20 mM 
Tris–HCl buffer pH 8 with 2% SDS plus pepstatin 10 μg/ml and 
heated to remove formalin cross-links.
Samples of the US cohort were sections from six ASC patients 
and five age, sex, and PMI matched control donors obtained as 
tissue micro-arrays (Eberhart et al., 2006) from the Autism Tissue 
Program (Harvard Brain Tissue Resource Center, Boston). One 
patient had a diagnosis of Rett syndrome, a  neurodevelopmental 
brain inflammation (Liu and Hong, 2003; Barger, 2005; Kim and 
Joh, 2006) and pro-inflammatory treatments of microglia acidify 
cellular lysosomes to a pH ∼5 (Majumdar et al., 2007). Preliminary 
characterization of this mechanism implicates activation of protein 
kinase A (PKA) and the activity of chloride channels (Majumdar 
et al., 2007). The transcriptional activity of NF-κB is stimulated 
upon phosphorylation of its p65 subunit on serine 276 by PKA 
(Zhong et al., 1998) and in turn PKA is a downstream target of the 
transcription factor (Kaltschmidt et al., 2006). With this in mind we 
postulated that an association may exist between the transcription 
factor and lysosomal acidity.
This article describes measurement of NF-κB p65 expression 
levels and pH in post-mortem samples of orbitofrontal cortex from 
patients with a diagnosis of ASC and control samples from people 
healthy at the time of death. We hypothesized that concentrations 
of NF-κB would be elevated in patients and pH would be con-
comitantly reduced (i.e., acidification), providing evidence for a 
neuroinflammatory component to ASC.
This hypothesis was initially tested by Western immunodetec-
tion of post-mortem brain tissue to measure overall, nuclear and 
cytosolic NF-κB expression.
Investigations were then focused upon microglial cells due to 
their role in pro-inflammatory response, as these most strongly 
mediate aberrant expression of NF-κB. Antigen retrieval and 
immunofluorescence techniques were used to identify the dif-
ferential concentrations of intracellular NF-κB in neurons, astro-
cytes, microglia, and highly activated (i.e., mature or functional) 
microglia. Immunoreactivity measurements were initially carried 
out to determine the concentration of NF-κB in the cytoplasm 
of each cell type as an indication of the availability of inactive 
Table 1 | Demographic information on tissue donors for the UK (London Brain Bank) and US (Autism Tissue Program/Harvard Brain Tissue Resource 
Center) cohorts.
Sample ID Autopsy no. Diagnosis Age (years) Sex Cause of death PMI* (hours) Cohort
A01 A091/95 ASC 20 M Epileptic seizure1 40 UK
A02 A195/95 ASC 24 M Drowning 24 UK
A03 A182/96 ASC 41 F Ovarian carcinoma2 7 UK
C01 A006/00 Control 61 M Cardiac arrest 53 UK
C02 A232/91 Control 32 M Sudden death unknown UK
C03 A102/89 Control 20 M Multiple injuries 48 UK
C04 A239/95 Control 79 F Chronic obstructive pulmonary disease 38 UK
A11 797 C ASC 9 M Drowning 13 US
A12 1315 C ASC 8 M Drowning 24 US
A13 1182 C ASC 9 F Smoke inhalation 9 US
A14 1174 C ASC 7 F Multi-organ failure 14 US
A15 1349 C ASC 5 M Drowning 39 US
R11 1194 C Rett syndrome 5 F Seizure/asphyxia 14 US
C11 1793 C Control 11 M Drowning 19 US
C12 877 C Control 8 F Trauma/hemorrhage 36 US
C13 1500 C Control 6 M Accident; multiple injuries 18 US
C14 1407 C Control 9 F Asthma 20 US
C15 1377 C Control 5 F Drowning 20 US
*Post-mortem interval.
1Epilepsy treated with carbamazepine and vigabatrin.
2Carcinoma treated with zuclopenthixol, fluconazole, ranitidine, omeprazole, prednisolone, and morphine.
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microglia (Hughes et al., 2003). This was followed by a final 5 min 
wash and slides were mounted with 4′,6-diamidino-2-phenylin-
dole (DAPI) with Vectashield (Vector Labs Ltd, UK) to identify 
cell nuclei.
One hundred cells of each type (neurons, astrocytes, and micro-
glia) from each sample were selected at random, blinded from 
group (i.e., ASC or control). Cells were graded for immunoreac-
tivity according to the intensity of antibody signal within the cell 
on an integer scale of 0–3 (Schmidt and Bankole, 1965). For each 
cell type, the percentage of cells with weak (scale 1) and strong 
(scale 3) intensity was calculated.
Antigen positive cells were also counted in each sample to quan-
tify the intensity of anti-p65 signal in the nucleus, providing a 
measurement of nuclear translocation of NF-κB p65 and thus the 
active state of the molecule within each cell type.
MeasureMent of ph
Equal volumes of neural tissue were homogenized using a mortar 
and pestle in 10 volumes of deionized water at 4°C. The pH of the 
homogenate was measured using a MeterLab PHM201 pH meter 
(Radiometer Analytical, Villeurbanne Cedex, France) calibrated 
with two standards for pH 4 and 7. Measurements were made eight 
times over 4 days and averaged to yield a final value.
Using the protocol described by Morgan and Galione (2007) and 
Lee et al. (1983), the pH of lysosomes was measured. Tissue sections 
were simultaneously loaded with 10 μM acridine orange and 1 μM 
Lysotracker Red DND-99 for 15–20 min at room temperature, at 
which time the fluorescence had reached equilibrium; that is, the 
dyes were present throughout the rest of the experiment. Acridine 
orange responds rapidly and profoundly to changes in pH, whereas 
Lysotracker Red responds only relatively slowly and remains essen-
tially fixed throughout the experiment. Results are expressed as the 
ratios of the acridine orange/Lysotracker Red signals such that an 
increase in the ratio reflects an increase in pH.
statIstIcal analysIs
Small sample sizes precluded valid formal between-group (i.e., ASC 
vs. control) statistical tests. Nevertheless, in many cases there was 
no overlap in the values obtained for each group. Unless indicated, 
all data are expressed as mean ± standard error across the samples. 
Statistical testing of within-group correlation was undertaken using 
SPSS (v17, SPSS Inc.), with the level for significance set at p < 0.05.
results
expressIon of nf-κB p65 In neural tIssue: uK cohort
Western immunodetection of neural tissue samples analyzed for 
overall NF-κB p65 expression is shown in Figure 1A. Densitometry 
demonstrated a 2.9-fold increase of NF-κB p65 expression in ASC 
samples; Figure 1B.
Nuclear translocation of NF-κB p65 is predominately associ-
ated with the activation of the transcription factor. Separated tis-
sue lysates were used to determine the subcellular location of p65 
expression. In control tissue NF-κB p65 was mainly located within 
the cellular cytoplasm, whereas in tissue samples from ASC patients 
the expression was predominately within the nucleus. Western 
immunodetection of neural tissues analyzed for overall NF-κB 
p65 expression for the UK cohort is shown in Figure 1C.
disorder classified as an ASC. The age-at-death of donors 
was considerably younger (5–11 years) than the UK cohort 
(20 –79 years; Table 1).
tIssue separatIon
Tissue samples from the UK cohort were processed for nuclear and 
cytosolic extraction using two separation buffers. The tissue was 
homogenized in 10 volumes of buffer 1 (Tris 10 mM, NaH
2
PO
4
 
20 mM, EDTA 1 mM, pH 7.8 PMSF 0.1 mM, pepstatin 10 μg/ml, 
and leupeptin 10 μg/ml). Homogenate was incubated for 20 min 
and osmolarity restored by adding 1/20 volume of KCl 2.4 M, 
1/40 volume of NaCl 1.2 M, 1/5 volume sucrose 1.25 M. Samples 
were spun for 5 min at 3,500 rpm, supernatant removed and pel-
let resuspended on 0.6 M sucrose and spun for a further 10 min 
at 10,000 rpm.
Subsequently, the supernatant was diluted in buffer 2 (imidazole 
30 mM, KCl 120 mM, NaCl 30 mM, NaH
2
PO
4
, sucrose 250 mM pH 
6.8, protease inhibitors pepstatin 10 μg/ml and leupeptin 10 μg/
ml) and spun again at 3,500 rpm for 15 min. The resultant pellets 
contained the remaining nuclear proteins, and the supernatants 
the cytosolic proteins.
Western IMMunodetectIon
Protein samples run on SDS-polyacrylamide gels were elec-
troblotted to nitrocellulose membranes (Schleicher & Schuell 
Bioscience GmbH, Germany), blocked with 5% non-fat dry milk 
in phosphate buffered saline with 0.1% Tween-20 (PBST), and 
probed with a 1:1,000 dilution of anti-p65 antibody (Santa Cruz 
Biotechnology). PBST washed membranes were then incubated 
with HRP-conjugated goat anti-rabbit antisera (Sigma Ltd, UK), 
and developed with enhanced chemiluminescence reagents (Pierce 
Ltd, UK). Signal was detected using a LAS 3000 image analyzer 
(Fujifilm, Japan) and bands quantified using ImageJ software.
IMMunofluorescence
Tissue samples were fixed in formalin and embedded in paraffin 
blocks. Slides were deparaffinized in xylene three times, each for 
5 min, then hydrated gradually through graded alcohols: washed 
in 100% ethanol twice for 10 min each, then 95% ethanol twice 
for 10 min each and finally washed in deionized water for 1 min 
with stirring. Sections were cut 5 μm thick and mounted onto these 
pre-treated slides.
Antigen retrieval was carried out in a pressure microwave where 
slides were covered in 10 mM sodium citrate buffer pH 6.0. After 
cooling for 20 min, sections were blocked in 10% normal goat block 
for 15 min and placed in anti-p65 NF-κB antibody 1:200 (Santa 
Cruz Biotechnology Inc., Santa Cruz, CA, USA) overnight at 4°C. 
Sections were washed continuously for 5 min and placed in HRP-
conjugated goat anti-rabbit antisera 1:200 (Molecular Probes Inc., 
Eugene, OR, USA) for 30 min at room temperature.
Sections were then stained with either: anti-Beta III Tubulin 
(1:10,000), a microtubule element antibody targeted exclusively in 
neurons; anti-GFAP (1:250), an intermediate filament (IF) protein 
antibody specific for astrocytes; anti-CD11b (1:250), a complement 
component 3-receptor 3-subunit antibody sensitive to microglia 
(Ford et al., 1995; Becher and Antel, 1996); or anti-CD11c (1:250), 
a type I transmembrane protein antibody found on highly activated 
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the control group had the majority of fluorescence scores in 
the range 0–1 (69%; Table 2). There was an increase in nuclear 
translocation of NF-κB p65 in neurons, within tissue from ASC 
patients (21.67 ± 1.50%) compared to controls (17.00 ± 1.41%; 
Figure 2A). Examples of CD11c, p65, and DAPI staining are 
shown Figure 3D.
Between-group differences in the immunoreactivity of astro-
cytes stained by anti-GFAP were observed with 80% of cells from 
ASC samples scoring 2–3 compared to 56% of cells from con-
trol samples scoring 0–1; Table 2. Differences in nuclear NF-κB 
p65 expression between ASC and control tissue samples were 
observed. On average 88.00 ± 4.00% of astrocytes in tissue from 
ASC patients demonstrated nuclear localization of the tran-
scription factor compared to 33.00 ± 3.16% in control samples; 
Figure 3A.
expressIon of nf-κB p65 In neurons, astrocytes, and 
MIcroglIa: uK cohort
The immunoreactivity intensity from neurons stained by anti-
Beta III Tubulin in tissue from ASC patients predominately 
scored in the range 2–3 (78%), whilst neurons in tissue from 
Table 2 | Immunoreactivities of each cell type on an integer scale of 0 (weakest) to 3 (strongest) intensities.
Cell type Control samples ASC samples
 0 1 2 3 0 1 2 3
Neurons (UK) 3.00 (2.16) 63.00 (3.65) 29.00 (1.63) 5.00 (4.08) 1.30 (1.15) 20.70 (2.52) 43.00 (2.65) 35.00 (2.65)
Microglia CD11b+ (UK) 4.75 (2.22) 54.50 (2.38) 22.25 (5.25) 18.50 (4.93) 5.33 (1.53) 14.00 (2.65) 32.70 (6.51) 48.00 (2.65)
Microglia CD11c+ (UK) 3.25 (2.75) 54.50 (8.54) 39.00 (5.83) 13.25 (5.12) 1.00 (1.00) 11.00 (3.00) 27.30 (20.30) 60.67 (9.50)
Astrocytes (UK) 3.00 (2.16) 53.00 (4.08) 35.00 (2.82) 9.00 (4.54) 1.00 (1.00) 19.30 (5.77) 35.00 (6.56) 44.67 (4.51)
Neurons (US) 1.20 (1.30) 62.20 (4.03) 31.20 (2.17) 5.20 (3.27) 1.83 (1.72) 25.80 (3.92) 38.70 (3.93) 33.67 (5.82)
Microglia CD11c+ (US) 1.40 (1.52) 51.20 (3.83) 31.40 (5.73) 16.00 (8.75) 2.33 (1.63) 12.30 (1.63) 28.30 (7.09) 56.67 (7.44)
Values are mean (across samples, with standard deviation) percentage of cells demonstrating corresponding staining.
FIgURe 1 | NF-κB in post-mortem tissue from the orbitofrontal cortex 
from ASC and control donors. (A) Image of Western blot probed with the 
anti-NF-κB p65 and anti-β-actin antibodies (loading control). Molecular mass 
markers are shown in kDa. (B) Relative expression of NF-κB p65 subunit, 
normalized to the lowest value recorded (Study ID C01). (C) Image of 
fractioned samples probed with anti-NF-κB p65. Sample IDs suffixed “/N” are 
the nuclear component, and suffixed “/C” the cytosolic component. Sample 
IDs prefixed “A” are from ASC donors, prefixed “C” from control donors.
FIgURe 2 | NF-κB p65 expression in neurons. (A) A representative image of 
a neuron stained with anti-β-III Tubulin (green), anti-p65 (red), and DAPI (blue). 
Scale bar = 10 μm. (B) Percentage of neurons with anti-p65 nuclear staining 
for each sample. Sample IDs prefixed “A” are from ASC donors, prefixed “C” 
from control donors.
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controls. These between-groups differences were increased in 
astrocytes and microglia relative to neurons, but particularly 
pronounced for highly active microglia identified by anti-CD11c 
staining.
expressIon of nf-κB p65 In neurons and MIcroglIa: us cohort
Immunoreactivity measurements of samples from the US 
cohort stained by anti-Beta III Tubulin for neuronal identifi-
cation revealed that 69% of cells from ASC samples scored 2–3, 
whilst 63% of cells from control samples scored 0–1; Table 2. 
Nuclear translocation of NF-κB p65 occurred in 20.83 ± 1.72% 
of cells in ASC samples compared to 14.60 ± 1.52% controls; 
Figure 2B.
Immunoreactivity analysis of CD11c positive microglia resulted 
in 85% of cells from ASC samples scoring 2–3, whilst 53% of cells 
from control samples scored 0–1; Table 2. Nuclear translocation 
occurred in 90.50 ± 6.66% of cells in ASC samples compared to 
22.00 ± 2.00% from controls; Figure 3C.
Due to limited sample volumes, processing and analysis for 
astrocytes and CD11b positive microglia was not undertaken.
Differences in immunoreactivity for CD11b positive microglia 
were also observed, with 81% of cells from ASC samples scoring 
2–3 compared to 59% of cells from control samples scoring 0–1; 
Table 2. The between-group difference in nuclear translocation in 
these cells was also more pronounced than in neurons. In CD11b 
positive microglia, 93.67 ± 3.00% of cells from samples from ASC 
patients expressed nuclear NF-κB p65 compared to 64.25 ± 1.26% 
from controls; Figure 3B.
Similarly, CD11c positive (highly active, mature) microglia in 
samples from ASC donors had raised levels of immunoreactivity 
with 88% of cells from ASC samples scoring in the range 2–3 com-
pared to 58% of cells from control samples scoring in the range 0–1; 
Table 2. Nuclear NF-κB p65 expression in CD11c positive microglia 
from ASC samples was 89.67 ± 2.08% of cells and 34.00 ± 2.16% from 
controls; Figure 3C. Furthermore, using 20 visual fields randomly 
selected blind to group, the number of active CD11c positive cells 
present was 3.75 times greater in tissue from ASC donors; Figure 3E.
In summary, all cell types demonstrated increased extranuclear 
and nuclear translocated NF-κB p65 expression in samples of 
brain tissue from ASC donors relative to samples from matched 
FIgURe 3 | NF-κB p65 expression in astrocytes and microglia. (A) 
Percentage of GFAP stained astrocytes with anti-p65 nuclear staining. 
(B) Percentage of CD11b stained microglia with anti-p65 nuclear staining. (C) 
Percentage of CD11c stained (highly activated) microglia with anti-p65 nuclear 
staining. (D) A representative microglial cell with nuclear NF-κB p65 staining 
with anti-CD11c (green), anti-p65 (red), and DAPI (blue). Scale bar = 20 μm. (e) 
The number of CD11c positive microglia found in 20 fields of random sampling. 
Blue bars represent samples from the UK cohort, red bars samples from the US 
cohort. Sample IDs prefixed “A” are from ASC donors, prefixed “C” from 
control donors.
Frontiers in Psychiatry | Molecular Psychiatry  May 2011 | Volume 2 | Article 27 | 6
Young et al. Aberrant NF-kappaB expression in ASC
ASC (Zimmerman et al., 2005), together with activated astrocyte 
and microglia in post-mortem brain tissue (Pardo et al., 2005). 
Nevertheless, the underlying molecular events remain unclear.
In this article, for the first time to our knowledge, we report 
the aberrant expression of a pro-inflammatory transcription fac-
tor, NF-κB, in samples donated to the London Brain Bank (UK 
cohort) and Harvard Brain Tissue Resource Center (US cohort). 
This discovery could play a major role in refining diagnostic tests 
and therapeutic interventions for ASC. Excess NF-κB p65 expres-
sion was observed in cytosolic, but predominantly nuclear com-
partments in ASC samples (Figure 1). These relative increases were 
subsequently localized to neurons, astrocytes, and microglia, but 
were particularly pronounced in highly activated (CD11c positive) 
microglia. Furthermore, nuclear translocation of NF-κB suggests 
activation of the molecule.
NF-κB induces the expression of inflammatory cytokines and 
chemokines and, in turn, is induced by them (Barnes and Karin, 
1997; Pahl, 1999). This establishes a positive feedback mechanism 
(Perkins, 2004), which has the potential, when NF-κB becomes 
aberrantly active, to produce the chronic or excessive inflammation 
associated with several inflammatory diseases (Barnes and Karin, 
1997; Mattson et al., 2000; Mattson and Meffert, 2006; Memet, 
2006).
Primarily in neurons, NF-κB is activated in order to provide a 
protective function. A small, 6% point difference between ASC and 
control groups suggests the presence of extensive stress on neurons 
These data confirmed results derived from the UK cohort, with 
differences in nuclear translocation of NF-κB p65 in neurons 6.23% 
points higher for ASC samples from the UK cohort and 4.67% points 
higher from the US cohort. In CD11c positive, highly activated 
microglia, between-group differences in nuclear translocation of 
NF-κB p65 were similarly elevated in the US cohort (68.50% points 
higher in ASC samples) and the UK cohort (55.67% points higher).
dIfferences In ph and relatIonshIp to nf-κB p65 expressIon: uK 
cohort
Measurement of homogenized tissue yielded a 0.92-unit pH between-
group difference (Figure 4A), decreased in ASC samples relative to 
control samples from the UK cohort. The relationship between pH and 
NF-κB p65 expression was explored by linear regression and a highly 
significant effect observed [F(1,5) = 98.3; p = 0.00018; Figure 4B].
Aberrant pH was localized to subcellular compartments by 
immunofluorescence. Low pH observed in homogenized tissue 
from ASC samples appears to be a result of a reduced pH in the 
lysosomal compartments of cells. Tissue from ASC patients had 
lysosomes that fluoresced green whereas that from controls fluo-
resced orange; Figures 4C,D.
dIscussIon
An emerging focus of research into ASC has suggested neuroin-
flammation as an underlying biological model, with evidence from 
irregular cytokine profiles in the cerebrospinal fluid of children with 
FIgURe 4 | Measurement of pH. (A) Graph of pH of homogenized tissue 
samples. (B) Plot of normalized overall expression of NF-κB p65 from 
quantification of Western blot vs. pH of homogenized samples with a 
superimposed line of linear regression. Filled circles are samples from ASC 
donors, open circles samples from control donors. (C) Immunofluorescent 
image from a tissue sample from control donor (×63 objective, scale 
bar = 20 μm) and (D) from a sample from ASC donor (×100 objective, scale 
bar = 20 μm). Images are pseudocolored and show the ratio of acridine orange/
Lysotracker Red fluorescence. Green hues represent low lysomic pH, and red 
hues represent high lysomic pH.
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Consistent observations of pH reduction in brain tissue from 
patients with schizophrenia have unclear origins, with medication 
and cause of death effects suggested in addition to it reflecting 
features of the disorder (Lipska et al., 2006; Halim et al., 2008). 
Thus, there remains the possibility that reductions in pH represent 
agonal artifact, and indeed ante mortem hypoxia and long termi-
nal phases as well as gender, are known to lead to pH reductions 
in post-mortem brain tissue (Monoranu et al., 2009), although 
there is no correlation with PMI and age at death. In this study 
donors were matched on all these quantities (Table 1). The linear 
modeling between NF-κB concentrations and pH is highly sig-
nificant and furthermore is located in the lysosomes (Figure 4) 
Nevertheless, a post-mortem change in pH from chemical cascades 
involving NF-κB cannot be excluded. Should further experimen-
tation confirm the relationship between these cellular markers of 
inflammation and pH, then this may be a potential biomarker for 
diagnosis and response to therapeutic interventions. Measurements 
of in vivo intracellular pH can be achieved non-invasively with 
 phosphorous-31 magnetic resonance spectroscopy (Pettegrew 
et al., 1988) or magnetization transfer techniques (Sun et al., 2007).
conclusIon
To summarize: NF-κB is aberrantly expressed in the orbitofrontal 
cortex as indicated by measurements on post-mortem tissue from 
ASC patients, and particularly in highly activated microglia. This 
region is a locus of abnormal function in ASC that underlies the 
abnormal development of social and cognitive skills (Sabbagh, 
2004). This is the first discovery of its kind that identifies a poten-
tial mechanism for neuroinflammation in ASC through increased 
expression of this pro-inflammatory molecule and the significant 
involvement of resident immune cells. The connection of this result 
to changes in intracellular acidity indicates an investigation of pH 
across the entire brain parenchyma in living patients.
Whilst evidence of causal link remains to be established, the idea 
that the induction of inflammation via the NF-κB signaling cascade 
is observed in regions of the neocortex associated with behavioral 
and clinical symptoms of ASC gives credence and impetus to inter-
ventions focusing on this potential therapeutic target.
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in ASC is unlikely. For confirmation, the cell morphology of neurons 
was screened (Mpoke and Wolfe, 2003) for signs of apoptosis or 
necrosis to assess the relative rates of cell death. There were minimal, 
if any, differences between-groups, an observation that concurs with 
work by Hausmann et al. (2004) who reported that apoptosis was not 
detected in non-traumatically injured brain tissue when the PMI was 
less than 72 h. The samples reported in the study fall into this category 
(Table 1). Although needing to be confirmed at the molecular level, 
this may well be a key finding as it demonstrates the potential revers-
ibility of the condition, something not commonly observed in many 
neurological disorders where there is high irreversible cell death.
The elevated nuclear translocation in ASC samples (Figure 3) 
supports previous work on astrocyte and microglia activation in the 
condition (Pardo et al., 2005; Vargas et al., 2005; Zimmerman et al., 
2005; Anderson et al., 2008). The activation of microglia induces an 
array of cellular events which accumulate to reduce neural function. 
This is potentially of interest more widely as previous studies have 
identified a potential link between low pH of homogenized tissue 
and learning disabilities (Rae et al., 2003) as well as Alzheimer’s 
disease (Majumdar et al., 2007).
Confirmation of the immunofluorescence results was obtained 
from an independent set of samples from the Autism Tissue Program 
at the Harvard Brain Tissue Resource Center (US cohort). Close 
correspondence in magnitude and direction of between-group dif-
ferences with the UK cohort was observed. However, it is worthy of 
note that samples from the US cohort were donated by people very 
much younger than the UK cohort. Thus, as well as validating the 
results from the UK cohort, the observation of aberrant expression 
of NF-κB can be extended to cover an age range from 5 to 40 years.
While the origin of inflammatory signaling in ASC remains 
undetermined, genetic or epigenetic factors are mechanisms 
which can subsequently up-regulate the NF-κB signaling cascade. 
Animals subject to prenatal immunological challenges during early 
gestation subsequently displayed marked learning deficits (Meyer 
et al., 2006) and morphological brain changes post-natally (Li et al., 
2009). Extracellular detection of pathogens by toll-like receptors 
leads to signaling pathways resulting in over-expression of NF-κB. 
Theoretically, this would allow for the range of environmental 
stimuli which are associated with the condition to act on a central 
node of the inflammatory component of the condition. Supported 
by the increase in NF-κB expression at the protein level, an inher-
ited component is most likely why the chronic inflammatory state 
maintains throughout adulthood.
The ∼1 unit pH difference observed in homogenate brain tissue 
from controls and ASC patients (Figure 4A) appears to be a result of 
increased lysosomal activity (Figures 4C,D). Coupled to the highly 
significant linear relationship between pH and NF-κB (Figure 4B), 
the inference is that acidification does not influence cognitive func-
tion directly, but is a consequence of neuroinflammation.
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